florbetaben F 18

CHEBI:CHEBI_754991

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
route
INTRAVENOUS
package_marketing_start_date
20220613
nui
N0000175869
pharm_class_epc
Radioactive Diagnostic Agent [EPC]
pharm_class
Positron Emitting Activity [MoA]
marketing_start_date
20140320
pharm_class_moa
Positron Emitting Activity [MoA]
generic_name
florbetaben F 18
brand_name
Neuraceq
brand_name_base
Neuraceq
product_ndc
54828-001
application_number
NDA204677
labeler_name
Life Molecular Imaging, Ltd
manufacturer_name
Life Molecular Imaging, Ltd
spl_id
70cad068-9da7-406f-a27c-f1297602cffa
active_ingredient_name
FLORBETABEN F-18
active_ingredient_strength
135 mCi/mL
package_ndc
54828-001-50
package_description
1 VIAL, MULTI-DOSE in 1 CONTAINER (54828-001-50) / 50 mL in 1 VIAL, MULTI-DOSE
unii
TLA7312TOI
spl_set_id
b0915068-cfd4-4d72-b9f8-7e31fe83cd1e
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class